These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21907187

  • 1. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
    Zhong WB, Hsu SP, Ho PY, Liang YC, Chang TC, Lee WS.
    Biochem Pharmacol; 2011 Dec 01; 82(11):1663-72. PubMed ID: 21907187
    [Abstract] [Full Text] [Related]

  • 2. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
    Zhong WB, Liang YC, Wang CY, Chang TC, Lee WS.
    Endocr Relat Cancer; 2005 Sep 01; 12(3):615-29. PubMed ID: 16172195
    [Abstract] [Full Text] [Related]

  • 3. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G.
    Carcinogenesis; 2005 Jun 01; 26(6):1021-34. PubMed ID: 15718252
    [Abstract] [Full Text] [Related]

  • 4. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.
    Chen MC, Tsai YC, Tseng JH, Liou JJ, Horng S, Wen HC, Fan YC, Zhong WB, Hsu SP.
    Int J Mol Sci; 2017 Dec 13; 18(12):. PubMed ID: 29236027
    [Abstract] [Full Text] [Related]

  • 5. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
    Zhong WB, Wang CY, Chang TC, Lee WS.
    Endocrinology; 2003 Sep 13; 144(9):3852-9. PubMed ID: 12933658
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J, Rao S, Keyomarsi K.
    Cancer Res; 1997 Feb 15; 57(4):604-9. PubMed ID: 9044834
    [Abstract] [Full Text] [Related]

  • 10. Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis.
    Park WH, Lee YY, Kim ES, Seol JG, Jung CW, Lee CC, Kim BK.
    Anticancer Res; 1999 Feb 15; 19(4B):3133-40. PubMed ID: 10652602
    [Abstract] [Full Text] [Related]

  • 11. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK, Lee YY.
    Cancer Res; 2000 Jun 01; 60(11):3065-71. PubMed ID: 10850458
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y, Buffolino P, Coppock DL.
    Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Ghosh PM, Ghosh-Choudhury N, Moyer ML, Mott GE, Thomas CA, Foster BA, Greenberg NM, Kreisberg JI.
    Oncogene; 1999 Jul 15; 18(28):4120-30. PubMed ID: 10435593
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A, Chen H, Xu XC.
    Cancer Epidemiol Biomarkers Prev; 2008 Jan 15; 17(1):88-94. PubMed ID: 18199714
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
    Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):309-14. PubMed ID: 18625202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.